QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

SEPN

QT65Septerna, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
36.17
+0.37+1.03%
OverviewShort InterestFilings
SEPNQT65Septerna, Inc.·NASDAQ
OverviewShort InterestFilings
36.17+1.03%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own4.04%
Shs Outstand45.08M
Perf Week6.29%
Market Cap1.61BForward P/E-EPS next Y-2.42Insider Trans0.23%Shs Float-Perf Month36.44%
Enterprise Value1.57BPEG-EPS next Q-0.42Inst Own-Short Float-Perf Quarter48.97%
Income-36308342.00P/S22.33EPS this Y-Inst Trans-Short Ratio-Perf Half Y37.90%
Sales72.26MP/B4.23EPS next Y-43.82%ROA-6.33%Short Interest-Perf YTD29.73%
Book/sh8.39P/C14.85EPS next 5Y-ROE-9.44%52W High37.32 -3.08%Perf Year253.22%
Cash/sh7.70P/FCF15.09EPS past 3/5Y-ROIC-11.28%52W Low9.85 267.21%Perf 3Y-
Dividend Est.-EV/EBITDA-30.03Sales past 3/5Y-Gross Margin99.42%Volatility3.98% 4.26%Perf 5Y-
Dividend TTM-EV/Sales21.66EPS Y/Y TTM44.04%Oper. Margin-77.07%ATR (14)1.98Perf 10Y-
Dividend Ex-Date-Quick Ratio4.71Sales Y/Y TTM-Profit Margin-49.88%RSI (14)72.43Recom1.80
Dividend Gr. 3/5Y-Current Ratio4.71EPS Q/Q61.22%SMA2013.74%Beta1.28Target Price50.00
Payout0.00%Debt/Eq0.06Sales Q/Q-SMA5030.34%Rel Volume0.83Prev Close35.80
Employees75LT Debt/Eq0.06EarningsAug 10SMA20046.01%Avg Volume342.29KPrice36.17
IPO DateOct 25, 2024Option/ShortYes / YesEPS/Sales Surpr.62.75% 58.82%Net Debt/EBITDA0.93Volume283,320Change1.03%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-11-26InitiatedGuggenheimBuy$52
Jun-08-26ReiteratedRaymond JamesStrong Buy$38 → $53
Mar-10-26ReiteratedCantor FitzgeraldOverweight$60
Jan-20-26ReiteratedH.C. Wainwright$30 → $35
Dec-19-25InitiatedRaymond JamesStrong Buy$38
Dec-15-25InitiatedTruistBuy$34
Nov-14-25UpgradeWells FargoEqual Weight → Overweight$18 → $28
May-16-25ReiteratedWells FargoEqual Weight$11 → $18
Mar-28-25ReiteratedWells FargoEqual Weight$14 → $11
Feb-18-25DowngradeWells FargoOverweight → Equal Weight$14
Latest News
Jun-17-26
Jun-17-2602:18AM
Septerna: A De-Risking GPCR Story With Near-Term Upside CatalystsSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
Total Revenue4610
Cost of Goods Sold Incl. D&A
000
Gross Profit4610
Selling, General and Administrative Excl. Other291710
Research and Development986536
Other Operating Expense00-48
Operating Income-81-812
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-32-948
Net Income Before Taxes-49-725
Income Taxes001
Consolidated Net Income-49-724
Net Income From Continuing Operations-49-724
Net Income-49-724
EPS (Recurring)-1.10-1.930.03
EPS (Basic, Before Extraordinaries)-1.10-1.930.03
EPS (Diluted)-1.10-1.930.03
EBITDA-47-71-45
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio26.67——
Gross Margin100.00100.00—
Operating Margin-176.09-8,100.00—
Net Margin-106.52-7,200.00—
Shares Outstanding443719
Market Capitalization1,227——
Operating Lease Expense
———
Insider Trading Volume
$37.99$35.78$33.56$31.34$29.13● Close Price0.00M0.49M0.99M1.48M1.98MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Shaikhly SamiraChief People OfficerJun 12 '26Option Exercise11.7012,500146,25023,750Jun 16 12:00 AM
Shaikhly SamiraChief People OfficerJun 12 '26Sale35.086,250219,224793Jun 16 12:00 AM
Shaikhly SamiraChief People OfficerJun 01 '26Option Exercise1.8711,87022,22211,614Jun 03 12:00 AM
Shaikhly SamiraChief People OfficerJun 01 '26Sale28.935,935171,682793Jun 03 12:00 AM
Shaikhly SamiraChief People OfficerMay 26 '26Option Exercise6.8123,596160,68823,043May 28 12:00 AM
Shaikhly SamiraChief People OfficerMay 26 '26Sale30.0611,798354,656793May 28 12:00 AM
Bhatt ElizabethPresident and COOApr 15 '26Option Exercise6.818,00054,480178,209Apr 17 12:00 AM
Bhatt ElizabethPresident and COOApr 15 '26Sale24.344,00097,344174,209Apr 17 12:00 AM
Shaikhly SamiraChief People OfficerMar 02 '26Option Exercise1.84140,906258,91471,246Mar 04 12:00 AM
Shaikhly SamiraChief People OfficerMar 02 '26Sale28.1070,4531,979,838793Mar 04 12:00 AM
Bhatt ElizabethPresident and COOFeb 18 '26Option Exercise6.818,00054,480178,209Feb 20 12:00 AM
Bhatt ElizabethPresident and COOFeb 18 '26Sale28.974,000115,861174,209Feb 20 12:00 AM
Long Daniel D.SVP, Drug DiscoveryNov 10 '25Sale18.063,50163,22392,911Nov 13 12:00 AM
Klein UweSVP, Biological SciencesAug 18 '25Option Exercise4.1046,016188,73633,027Aug 19 12:00 AM
Finer JeffreyCEO and PresidentApr 03 '25Option Exercise2.7610,00027,600826,907Apr 04 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR